Commentary: Mind the buzz over diabetes drugs such as Wegovy and Ozempic, which are used also for weight loss

Philippines News News

Commentary: Mind the buzz over diabetes drugs such as Wegovy and Ozempic, which are used also for weight loss
Philippines Latest News,Philippines Headlines
  • 📰 TODAYonline
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 99%

Headlines are buzzing with the excitement that the ​United States ​Food and Drug Administration (FDA) will soon designate Mounjaro to join Wegovy and Ozempic as the latest diabetes medication approved as weight loss drugs.

Wegovy and Ozempic can now also be prescribed for patients suffering from obesity under the discretion of a medical professional, and there have been reports of more patients requesting to be put on these drugs, despite not suffering from diabetes or being obese.

Despite the existence of such weight loss programmes, globally, the health of many continues to decrease as their body fat continues to increase. They were first approved by the FDA in 2005 to treat Type-2 diabetes. They work by lowering blood sugar levels and increasing satiety — that feeling of fullness — to prevent overeating.

Most notably, the majority of patients who stop taking these drugs gain the weight back — repeating the frustrating cycle that so many people experience.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TODAYonline /  🏆 1. in SG

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Commentary: Mind the buzz over new diabetes drugs used also for weight loss. There are no shortcuts to slimming downCommentary: Mind the buzz over new diabetes drugs used also for weight loss. There are no shortcuts to slimming downHeadlines are buzzing with the excitement that the ​United States ​Food and Drug Administration (FDA) will soon designate Mounjaro to join Wegovy and Ozempic as the latest diabetes medication approved as weight loss drugs.
Read more »

Commentary: 'This desk is mine' - how noisy offices can make us more territorialCommentary: 'This desk is mine' - how noisy offices can make us more territorialNoisy offices can cause frustration and anger, as well as antisocial behaviour in employees, says a University of Queensland professor.
Read more »

Commentary: China is so far ahead in the EV market it’s a warning for EuropeCommentary: China is so far ahead in the EV market it’s a warning for EuropeThe Munich motor show was dominated by Chinese electric vehicles for the European market, giving the sense of an industry left behind, says the Financial Times’ Helen Thomas.
Read more »

Commentary: Should we be worried about mandarin ducks and parakeets squeezing out Singapore’s native birds?Commentary: Should we be worried about mandarin ducks and parakeets squeezing out Singapore’s native birds?Non-native birds have recently delighted bird enthusiasts and the general public. It is a great starting point to appreciate Singapore’s biodiversity, says Sin Yong Chee Keita from the Bird Society of Singapore.
Read more »

Commentary: Contrary to what TikTok tells you, ‘lazy girl jobs’ aren’t lazy at allCommentary: Contrary to what TikTok tells you, ‘lazy girl jobs’ aren’t lazy at allLazy girl jobs, trending on TikTok, grant employees flexibility and work-life balance - but they aren’t a free pass to slack off, says university student Audrey Wan.
Read more »

Commentary: Going on holiday will look very different because of climate changeCommentary: Going on holiday will look very different because of climate changeChanging climate conditions will affect where humans can safely or comfortably travel to. Tourists may start looking for cooler destinations as global temperatures rise, says this tourism researcher.
Read more »



Render Time: 2025-03-06 08:37:32